PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,930,803 | -11.4% | 2,219,826 | +12.5% | 0.00% | -33.3% |
| Q2 2023 | $25,872,899 | -11.5% | 1,973,524 | -24.5% | 0.00% | 0.0% |
| Q1 2023 | $29,228,667 | +61.2% | 2,614,371 | +21.6% | 0.00% | +50.0% |
| Q4 2022 | $18,128,758 | -41.3% | 2,150,505 | +16.0% | 0.00% | -50.0% |
| Q3 2022 | $30,885,000 | -1.4% | 1,853,823 | -12.9% | 0.00% | 0.0% |
| Q2 2022 | $31,320,000 | +448.6% | 2,127,771 | +824.8% | 0.00% | +300.0% |
| Q1 2022 | $5,709,000 | +165.4% | 230,073 | +243.1% | 0.00% | – |
| Q4 2021 | $2,151,000 | +216.3% | 67,049 | +255.2% | 0.00% | – |
| Q3 2021 | $680,000 | -76.3% | 18,878 | -71.0% | 0.00% | – |
| Q2 2021 | $2,870,000 | +41.0% | 65,036 | +46.1% | 0.00% | – |
| Q1 2021 | $2,036,000 | +108.0% | 44,503 | +213.7% | 0.00% | – |
| Q4 2020 | $979,000 | – | 14,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |